(Q35608979)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14678517%20AND%20SRC:MED&resulttype=core&format=json

22 December 2019

review article

1 reference

title

Alteration of the fragile histidine triad gene early in carcinogenesis: an update (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14678517%20AND%20SRC:MED&resulttype=core&format=json

22 December 2019

1 reference

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14678517%20AND%20SRC:MED&resulttype=core&format=json

22 December 2019

author name string

Hideshi Ishii

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14678517%20AND%20SRC:MED&resulttype=core&format=json

22 December 2019

Keiya Ozawa

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14678517%20AND%20SRC:MED&resulttype=core&format=json

22 December 2019

publication date

1 November 2003

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14678517%20AND%20SRC:MED&resulttype=core&format=json

Journal of Experimental Therapeutics & Oncology

22 December 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14678517%20AND%20SRC:MED&resulttype=core&format=json

22 December 2019

volume

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14678517%20AND%20SRC:MED&resulttype=core&format=json

22 December 2019

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14678517%20AND%20SRC:MED&resulttype=core&format=json

22 December 2019

page(s)

291-296

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14678517%20AND%20SRC:MED&resulttype=core&format=json

FRA3B and other common fragile sites: the weakest links

22 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1533-869X.2003.01101.X

Potential cancer therapy with the fragile histidine triad gene: review of the preclinical studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1533-869X.2003.01101.X

Fragile and unstable chromosomes in cancer: causes and consequences

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1533-869X.2003.01101.X

Cancer and the FRA3B/FHIT fragile locus: it's a HIT

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1533-869X.2003.01101.X

FHIT gene therapy prevents tumor development in Fhit-deficient mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1533-869X.2003.01101.X

Abnormal Fhit expression is an independent poor prognostic factor for cervical cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1533-869X.2003.01101.X

Loss of Fhit expression as a potential marker of malignant progression in preinvasive squamous cervical cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1533-869X.2003.01101.X

Restoration of fragile histidine triad (FHIT) expression induces apoptosis and suppresses tumorigenicity in lung and cervical cancer cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1533-869X.2003.01101.X

Restored expression of fragile histidine triad protein and tumorigenicity of cervical carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1533-869X.2003.01101.X

Aberrant FHIT transcripts in acute myeloid leukaemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1533-869X.2003.01101.X

Clinical significance of fragile histidine triad gene expression in adult acute lymphoblastic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1533-869X.2003.01101.X

Aberrant transcripts of the FHIT gene are expressed in normal and leukaemic haemopoietic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1533-869X.2003.01101.X

Altered PTEN expression as a diagnostic marker for the earliest endometrial precancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1533-869X.2003.01101.X

Expression of the retinoblastoma-related gene Rb2/p130 is downregulated in atypical endometrial hyperplasia and adenocarcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1533-869X.2003.01101.X

Reduced Fhit expression occurs in the early stage of esophageal tumorigenesis: no correlation with p53 expression and apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1533-869X.2003.01101.X

FHIT (fragile histidine triad) gene analysis in cervical intraepithelial neoplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1533-869X.2003.01101.X

Frequent altered expression of fragile histidine triad protein in human colorectal adenomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1533-869X.2003.01101.X

10.1111/J.1533-869X.2003.01101.X

21 January 2018

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14678517%20AND%20SRC:MED&resulttype=core&format=json

22 December 2019

1 reference